Aventis agrees to purchase Regeneron cancer treatment
Article Abstract:
Aventis S.A. has acquired Regeneron Pharmaceuticals Inc. early-phase cancer drug. The deal is valued at $510 million (459.2 milion euros).
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
United States, Product information, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Anticancer Drugs, Chemotherapeutic Drugs, Anticancer Immunostimulant Preps, Pharmaceutical industry, Company acquisition/merger, Antineoplastic agents, Regeneron Pharmaceuticals Inc., Antimitotic agents
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Bayer plans to buy unit from Aventis for 5.5 billion euros
Article Abstract:
Bayer AG has reached a deal to acquire Aventis S.A.'s Crop Science operations. The deal is valued at almost 5.5 billion euros.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
Asset sales & divestitures, Foreign operations, Germany, Scientific Research and Development Services, Chemicals & Allied Products, Chemical Manufacturing, CHEMICALS AND ALLIED PRODUCTS, Agricultural Chemicals, Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing, Research & Development NEC, Research institutes, Chemicals, Chemical industry, Agricultural chemicals industry, Bayer AG, Aventis CropScience S.A., BAYZY
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: High technology industry, Mergers, acquisitions and divestments, France, Aventis S.A., AVE
Similar abstracts:
- Abstracts: BASF aims to bulk up globally. Schering may buy remaining stake in Aventis unit. Schering names Erlen its new chief executive
- Abstracts: U.S.-led group is in talks to buy key stake in Astra. Astra sells microchip unit: U.S. Group buys Batam factory for $90 million
- Abstracts: Euronext makes LSE pitch. Nasdaq to acquire control of Easdaq for 70 million euros
- Abstracts: Reconfiguring its strategy; Fugitsu Siemens to focus on selling servers and mobile computers. Amazon.com plans to sell PCs online
- Abstracts: Air France offers a stake to pilots in labor pact. France Telecom to issue up to $10.7 billion of shares. France Acts Over Mad-Cow Disease
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.